Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 69

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 69
---
               |  4,215,711 |     |            |  4,215,711 |
|              | Disability |             |     |       -0- |           |     |     4,215,711 |            |     |  4,215,711 |            |
|              | Retirement |             |     |       -0- |           |     |           -0- |            |     |        -0- |            |

| (1) | For Dr. Sutaria and Mr. Arnst, represents a pro-rata AIP bonus for 2024 based on actual performance, as described in more detail above. |

| (2) | Unvested performance-based RSU awards are reported as vesting at target levels. Amounts reflected are based on the NYSE closing price of $126.23 per share of our common stock on December 31, 2024. |

Non-CauseTermination/No Change of Control Subject to the terms of the ESP and applicable equity plans and award agreements, including execution of a severance agreement containing restrictive covenants and a release of claims, Mr. Park, Mr. Arnst, Ms. Foo and Ms. Arbour are entitled to the following severance payments and other benefits if the executive’s employment is terminated by the Company without cause or by the executive for good reason (a “non-cause”termination), outside the context of a change of control of the Company:

| • |     | Lump sum pro-rata bonus earned under the AIP for the year that includes the date of termination. |

| • |     | Continued coverage during the severance period under medical, dental, vision, life insurance and long-term care benefit programs, provided that the executive continues to pay his or her portion of the cost of such coverages as in effect upon termination, and reduced to the extent that the NEO receives comparable benefits through other employment during the severance period. |

| • |     | Outplacement services not to exceed $25,000. |

| • |     | Pursuant to the terms of the ESP, the NEOs will forfeit any non-vested outstanding equity awards at termination to the extent the underlying equity award agreements do not otherwise provide for acceleration of vesting. Time-vested RSU awards and stock options vest upon a non-cause termination. Likewise, subject to satisfaction of the performance criteria, performance-based RSU awards and performance-based stock options vest upon a non-cause